Authorities failed to grasp the scale of risk to human life posed by heatwaves, the CEO of reinsurance company Swiss Re was quoted as saying on Sunday, as Europe faces mounting deaths linked to extreme summer temperatures.
Swiss Re AG (SSREY) Q2 2026 Earnings Call Transcript
The reinsurer said its property-and-casualty segment benefited from low large losses and its life-and-health segment from favorable U.S. mortality trends.
Paul Murray, CEO of Life and Health Reinsurance at Swiss Re, says inflation risks in Asia due to the Iran war and rising energy prices are a key concern for the insurance sector in the region. He also shares a snapshot of trends in medical insurance claims in Asia, which include an explosion in mental health and disability claims.
Swiss Re AG (SSREY) Shareholder/Analyst Call Transcript
Swiss Re's P&C Reinsurance delivered exceptional performance, with a 79.4% combined ratio and net income more than doubling year-over-year, supporting robust earnings quality. SSREF's $1.5 billion share buyback (~3% of market cap) and $8.00 DPS (+9% yearly) are supported by a 250% solvency ratio, providing significant financial flexibility. Improving reinvestment yields and a reset in Life & Health Reinsurance should support earnings recovery and strengthen the division's profitability.
Swiss Re AG (SSREY) Q4 2025 Earnings Call Transcript
Swiss Re AG (SSREY) Q4 2025 Earnings Call Transcript
The reinsurer posted a decline in fourth-quarter net profit on a softer top line, falling to $717 million from the $1.05 billion reported the year prior.
Swiss Re AG (SSREY) Discusses Strategic Outlook and Mindset for Achieving Market Leadership Transcript
The group continues to aim for annual dividend per share growth of 7% or more over next two years and to complement this with an annual share buyback program starting in 2026.
With excess capital, we expect Swiss Re to announce a meaningful buyback at the December 5th investor event. Despite L&H volatility, underlying P&C profitability remains in the low-80s combined-ratio range, and reinvestment yields continue to rise. This will support the 2026 results. Q3 results delivered a clear beat, and a 268% Solvency II ratio will support Swiss Re's financial stability. We remain buyers.